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Background: We present a descriptive and retrospective analysis of revision total hip arthroplasties (THA) using the
MRP-TITAN stem (Peter Brehm, Weisendorf, GER) with distal diaphyseal fixation and metaphyseal defect augmentation.
Our hypothesis was that the metaphyseal defect augmentation (Impaction Bone Grafting) improves the stem survival.
Methods: We retrospectively analyzed the aggregated and anonymized data of 243 femoral stem revisions. 68 patients
with 70 implants (28.8%) received an allograft augmentation for metaphyseal defects; 165 patients with 173 implants
(71.2%) did not, and served as controls. The mean follow-up was 4.4 ± 1.8 years (range, 2.1–9.6 years). There were no
significant differences (p > 0.05) between the study and control group regarding age, body mass index (BMI), femoral
defects (types I-III as described by Paprosky), and preoperative Harris Hip Score (HHS). Postoperative clinical function
was evaluated using the HHS. Postoperative radiologic examination evaluated implant stability, axial implant migration,
signs of implant loosening, periprosthetic radiolucencies, as well as bone regeneration and resorption.
Results: There were comparable rates of intraoperative and postoperative complications in the study and control groups
(p > 0.05). Clinical function, expressed as the increase in the postoperative HHS over the preoperative score, showed
significantly greater improvement in the group with Impaction Bone Grafting (35.6 ± 14.3 vs. 30.8 ± 15.8; p≤ 0.05). The
study group showed better outcome especially for larger defects (types II C and III as described by Paprosky) and stem
diameters≥ 17 mm. The two groups did not show significant differences in the rate of aseptic loosening (1.4% vs. 2.9%)
and the rate of revisions (8.6% vs. 11%). The Kaplan-Meier survival for the MRP-TITAN stem in both groups together was
93.8% after 8.8 years. [Study group 95.7% after 8.54 years ; control group 93.1% after 8.7 years]. Radiologic evaluation
showed no significant change in axial implant migration (4.3% vs. 9.3%; p = 0.19) but a significant reduction in proximal
stress shielding (5.7% vs. 17.9%; p < 0.05) in the study group. Periprosthetic radiolucencies were detected in 5.7% of the
study group and in 9.8% of the control group (p = 0.30). Radiolucencies in the proximal zones 1 and 7 according to
Gruen occurred significantly more often in the control group without allograft augmentation (p≤ 0.05).
Conclusion: We present the largest analysis of the impaction grafting technique in combination with cementless distal
diaphyseal stem fixation published so far. Our data provides initial evidence of improved bone regeneration after graft
augmentation of metaphyseal bone defects. The data suggests that proximal metaphyseal graft augmentation is beneficial for
large metaphyseal bone defects (Paprosky types IIC and III) and stem diameters of 17 mm and above. Due to the limitations
of a retrospective and descriptive study the level of evidence remains low and prospective trials should be conducted.
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The long-term success of femoral revision arthroplasty
depends on several factors. First, the joint’s physiologic
biomechanics should be restored by reconstructing the
anatomic center of rotation. Then, the implant fixation
should provide initial stability and allow full weight
bearing. A third and crucial factor is the biological
reconstruction of femoral bone defects, to restore a
functional implant bed capable of bearing physiologic
loads [1], and to downgrade the femoral defect situation
to facilitate a possible subsequent revision procedure [2].
The consensus in the current literature is that implant
fixation simply by filling the femoral defects with bone
cement leads to poor long-term results and should not
be recommended [3]. The bone cement cannot provide
an intrusive, interlocking bond in a smooth-walled
osteolytic femoral canal [4]. Cemented fixation can be
combined with Impaction Bone Grafting [5-8]. The fem-
oral canal is filled with bone grafts to obtain a normally
dimensioned implant bed, then the implant is cemented
[9]. The success rate of this method varies in the litera-
ture [10-12]. Potential disadvantages include impaired
union due to cement penetration into the graft [13] and
the increased risk of postoperative femoral fractures at
the level of osteolytic areas [14].
Cementless revision implants were initially devel-
oped as single component implants, but modular designs
have become increasingly popular [15,16]. Modular
implant systems provide greater variability in difficult
anatomical situations compared to monoblock revision
stems. The modular design can be adapted to the
individual surgical setting, allowing nearly physiologic
joint reconstruction [17].
Cementless revision stems are available with two dif-
ferent fixation concepts. Revision stems with a rough
proximal surface and metaphyseal fixation promote
proximal stress transfer, counteracting stress shielding
and progressive bone loss. Even though metaphyseal
stem fixation can be difficult to achieve in the presence
of extensive proximal osteolysis. Results are often unsat-
isfactory in such cases [18,19]. On the other hand, stems
that employ the initial distal diaphyseal press fit concept
entail a risk of stress shielding in the proximal femur
[15,20]. We present the surgical technique and the de-
scriptive mid-term follow-up results of the modular
MRP-TITAN revision stem (Peter Brehm, Chirurgie-
Mechanik, Weisendorf, Germany) with initial distal
diaphyseal fixation with or without supplementary meta-
physeal defect augmentation.
Methods
Patients
The results of 265 femoral revisions performed in 255
patients were followed in a multicenter patient registry.Patients were treated in four centers focusing on pri-
mary and revision THA in Germany. All patients
received the MRP-TITAN stem. Inclusion criteria were
revision THA with bony defects of the proximal femur
graded as Paprosky I- III. Exclusion criteria included all
kinds of tumors or secondary neoplasia diseases, NYHA
IV and ASA IV. A total of 8 surgeons performed the
operations. All surgeons were experienced attendings
and board certified orthopedic-surgeons doing more
than 100 primary or revision THAs a year. 22 patients
were lost to follow up, thus clinical and radiographic
findings were evaluated in 233 patients with 243
implants with a follow-up period of at least 2 years. 68
out of these patients with 70 implants (28.8%) recei-
ved an allograft augmentation of metaphyseal defects
using the implant-specific Impaction Bone Grafting
System (Peter Brehm, Chirurgie-Mechanik, Weisendorf,
Germany). 165 patients with 173 implants (71.2%) did
not receive metaphyseal defect augmentation and served
as controls.
Our hypothesis was that Impaction Bone Grafting
improves stem survival. The endpoint of our study was
revision surgery of the stem. Patients were retrospectivly
and descriptivly analysed using aggregated and anon-
ymized data.
The decision whether the Impaction Bone Grafting
technique was used or not was made intraoperativly by
the surgeon based on clinical criteria such as defect size,
defect location and containment. A relevant selection
bias could be excluded because both groups, patients
with and without IBG, did not vary significantly accord-
ing to age, sex, weight, height, body mass index (BMI),
intraoperative femoral defects as described by Paprosky
et al. [21], implant stem diameter, and preoperative func-
tion as measured by the HHS (Table 1).
Clinical evaluation
The mean follow-up period was 4.4 ± 1.8 years (min.-
max. 2.1–9.6 years). Clinical evaluation included the
duration of surgery, duration of hospitalization, time
of mobilization, time to full weight bearing, intrao-
perative and postoperative complications, improvement
of the HHS, and the causes of revision surgery and
implant failure.
Radiographic evaluation
Analogue, standardized plain pelvis radiographs with a
scale of 1:1.15 and a Lauenstein view of the symptomatic
hip were routinely obtained preoperatively. The follow
up radiographs were evaluated in a blinded fashion for
radiologic signs of implant loosening according to the
criteria published by Kavanagh and Fitzgerald [22]. Prox-
imal femoral bone defects were evaluated according to
the classification described by Paprosky et al. [21].
Table 1 Patient data in the study and control groups
Study group
(n = 70)
Control group
(n = 173)
p value
Patient data
Age [years] 69.2 ± 9.9 67.1 ± 9.8 0.14
Sex [m / f] 23 / 47 69 / 104 0.31
(% male) 32.9 39.9
Weight [kg] 73.4 ± 11.4 76.7 ± 14 0.08
Height [m] 1.66 ± 0.09 1.68 ± 0.1 0.12
BMI [kg / m2] 26.2 ± 3.9 26.7 ± 4.4 0.42
HHS preop. 35.5 ± 14.3 39.4 ± 15.7 0.07
Femoral defects (I – III Paprosky classification)
[intraoperative findings]
Type I [n] (%) 4 (5.7) 12 (6.9) 0.73
Type II A [n] (%) 20 (28.6) 55 (31.8) 0.62
Type II B [n] (%) 15 (21.4) 33 (19.1) 0.68
Type II C [n] (%) 12 (17.1) 35 (20.2) 0.58
Typ III [n] (%) 19 (27.1) 38 (22) 0.39
MRP-TITAN stem diameter
13 / 14 mm [n] (%) 10 (14.3) 22 (12.7) 0.74
15 / 16 mm [n] (%) 21 (30) 56 (32.4) 0.72
17 / 18 mm [n] (%) 24 (34.3) 59 (34.1) 0.98
19 / 20 mm [n] (%) 13 (18.6) 35 (20.2) 0.77
≥ 21 mm [n] (%) 2 (2.9) 1 (0.6) 0.15
Figure 1 Impaction grafting system (IGS). Special impactors in
sizes 3, 5 and 7 mm and extension sleeve (Peter Brehm GmbH,
Weisendorf, Germany) to be used for the proximal metaphyseal
allograft augmentation, using the press fit impaction technique.
Wimmer et al. BMC Musculoskeletal Disorders 2013, 14:19 Page 3 of 11
http://www.biomedcentral.com/1471-2474/14/19Evaluation of follow-up radiographs included assess-
ment of signs of loosening or periprosthetic radiolucencies
in zones 1–7 according to Gruen as well as secondary
axial implant migration, varus or valgus tilt, and rotation.
Implants showing axial migration of more than 5 mm,
progressive signs of osteolysis or complete periprosthetic
radiolucency were evaluated as unstable or loosened. Im-
plant tilting was determined comparing the angle between
the longitudinal axis of the femoral diaphysis and the im-
plant stem. Changes of more than 5 degrees occurring
over the observed course were regarded as significant.
Stem rotation was evaluated by comparing the radiologic
landmarks of the implant with the femur landmarks. Peri-
prosthetic bone regeneration, bone resorption, progressive
radiolucencies, and visible osteolysis were evaluated
according to the criteria described by Engh et al. [23].
Periarticular ossification was evaluated using the criteria
described by Brooker et al. [24]. All measurements were
done manually by a blinded investigator, not knowing
whether IBG was used or not.
Implant
The modular MRP-TITAN revision stem is a system
based on modular taper connections designed for
cementless implantation with initial distal diaphyseal fix-
ation. The implant components are made of a titanium
alloy (TiAl6Nb7) with a rough corundum-blasted surfacewith a pore size of 40–60 μm to facilitate osseous
integration.
The modular design essentially consists of three
components:
– The distally tapered femoral stem with longitudinal
parabolic ribs for fixation with rotational stability. The
stem is available as a straight-stem model in 140 mm
and 200 mm length, and curved-stem version to fit the
physiologic anterior bow of the femur in 200 mm
length. 260 mm and 320 mm curved stems with two
distal transverse drill holes are also available, providing
the possibility to use distal locking bolts for additional
stability. Diameters are available in 1 mm increments
between 13 and 22 mm.
– An optional extension sleeve, adding 30 mm to the
stem length.
– Three different neck models (sizes 50, 60, and
70 mm) with a standard taper (Euro taper 12/14). The
neck components are available with different neck-stem
angles of 130° (37 mm offset) and 123° (47 mm offset).
The core of the system is a taper connection using
optimized materials. This connection permits individual
adjustment of the angle of femoral anteversion and axial
coupling of the individual components. The continu-
ously adjustable taper connections are locked intraopera-
tively with extension bolts at a torque of 25 Nm, using
an implant-specific torque wrench. The modular design
allows intraoperative adaption of total implant length
from 190 mm to 420 mm with freely adjustable rotation.
A special impactor (diameter 3, 5 or 7 mm) is available
as an additional instrument for proximal metaphyseal
allograft augmentation, using the press fit impaction
technique (impaction grafting system, IGS, Figure 1).
The implant is designed to facilitate diaphyseal im-
plant fixation and covers the indications as follows:
– Stem loosening with deficient osteolytic bone stock
(type I-III femoral defects as described by Paprosky).
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periprosthetic fractures.
– Bone loss following tumor surgery.
Due to the principle of the implant, extensive meta-
physeal and diaphyseal defects with cortical thinning
and a wide diaphyseal medullary canal, which would
render diaphyseal press fit fixation difficult (type IV fem-
oral defects as described by Paprosky), must be consid-
ered a contraindication.
Surgical technique
The surgical procedure was modified from the previ-
ously described technique according to Mumme et al.
[25]. First, the stem of the primary implant was
removed. If a cemented stem was in place, the proximal
cement was removed with an osteotome. The distal ce-
ment mantle was then removed with reamers of differ-
ent diameters under continuous fluoroscopic control.
Occasionally the stem could not be removed in this
manner or cement residues remained. In these cases, a
rectangular cortical window was opened in the femoral
shaft over the residual cement and the implant was
removed through the femur. The bone removed to cre-
ate the cortical window was replaced and fixed after-
wards. The femoral canal was then reamed with flexible
reamers of increasing sizes. Reaming continued until the
reamer was in full contact with the bone on all sides
within a circular canal over a distance of 7–10 cm in the
distal diaphyseal fixation zone. Next, a trial stem of the
appropriate length and diameter (diameter 2–3 mm
larger than the last reamer used) was inserted using the
impactor/extractor with the central guide wire. The trial
stem was inserted according to the physiologic anterior
bow of the femur and far enough distally to achieve a
diaphyseal press fit over a length of 7–10 cm. After
determination of the definite size of the distal stem
component, the appropriate implant neck length was
measured, using the greater trochanter as a landmark.
The selected neck trial was then attached over the guide
wire and the desired rotation was selected. A trial head
was attached and a trial reduction performed. Once the
proper implant placement was determined in fluoros-
copy and by clinical examination, the trial was removed
and the definitive stem of the selected length and diameter
was implanted.
The study group received proximal defect augmenta-
tion with impaction grafting. Commercially available
allograft bone chips with an average size of 5–10 mm3
were produced with Luer forceps or with a bone grinder.
The technique avoided the use of a heat-producing saw.
The bone grafts were introduced into the metaphysis in
layers. Each layer was meticulously compressed using
the impaction grafting system (IGS) with impactors insizes of 3, 5, and 7 mm. Care was taken to obtain a uni-
form mixture of various particle sizes so as to optimize
surface contact among the chips [26] (Figure 2).
Next the selected definite neck component was per-
manently seated on the proximal end of the stem. The
taper connection between stem and neck components
was then tightened with an axial extension bolt using
the torque wrench (25 Nm) while the assistant applied
counter-torque with the holding device, after which the
locking bolt was inserted. After the definitive head was
attached, the joint was then reduced.
Statistical analysis
The analogically recorded values out of the register were
digitized and exported to MS Excel 2007 (Microsoft,
Redmond, WA, USA) and SPSS 17 (IBM, Armonk, NY,
USA). Equality of variance for an unpaired t-test was
evaluated in a Levené test. Individual comparisons were
analyzed using chi-square cross tabulations and the cor-
responding Fischer exact test, which determined the
likelihood quotient. The Kaplan-Meier survival rates
were determined by SPSS 17.
Results
Clinical evaluation & complications
There was no significant difference between the study and
control groups regarding the mean follow up [4.4 ± 1.7 vs.
4.4 ± 1.8 years, p = 0.93]. The Kaplan-Meier survival prob-
ability for the MRP-TITAN stem in both groups together
was 93.8% after 8.8 years (95% CI 8.41–9.21). [Study group
95.7% after 8.54 years (95% CI 7.83-9.08); control group
93.1% after 8.7 years (95% CI 8.19-9.20)].
Clinical examination showed significant improvement
in the HHS from 35.5 ± 14.3 to 71 ± 9.1 (study group,
p < 0.05) and 39.4 ± 15.7 to 70.2 ± 12.2 (control, p < 0.05).
The study group showed a significant higher improve-
ment in preoperative vs. postoperative Harris Hip Score
(30.8 ± 15.8 vs. 35.6 ± 14.3; p < 0.05). Duration of surgery
varied significantly between the two groups (p < 0.05)
[232 ± 63.3 min for the study group vs. 186 ± 59.4 min
for the control group], while duration of hospitalization,
time of mobilization, and time of full weight bearing did
not. The data is summarized in Table 2.
The frequency of intraoperative complications was the
same in both groups [10% (n = 7 ) in the study group vs.
10.4% (n = 18) in the control group, (p = 0.93)]. Three
shaft fissures (4.3%) occurred in the study group and 9 in
the control group (5.2%; p = 0.77). One shaft fracture
(1.4%) which occurred intraoperativly in the study group
and 2 shaft fractures in the control group (1.2%; p = 0.86)
were treated by open reduction and internal fixation. One
avulsion fracture of the greater trochanter in the study
group and 3 in the control group were reduced and stabi-
lized by tension banding (1.4% vs. 1.7%; p = 0.87).
Figure 2 Surgical technique. Filling metaphyseal bone defects by impaction bone grafting, using the press fit impaction technique. Special
impactors fit over the central guide rod and laterally “bypass” the trial implant, permitting meticulous compression of the allograft chips
introduced into the metaphysis. (A.) Illustration from [25]; (B) intraoperative photograph.
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significantly between the study and control groups [n = 8
(11.4%) in the study group vs. n = 23 (13.3%) in the con-
trol group, p = 0.69]. Six implants (8.6%) in the study
group and 19 implants (11%) in the control group
required surgical revision (p = 0.58). The causes for
revision in the study group included one nonrecurring
periprosthetic late infection after 4.4 years and one
periprosthetic fracture occurring as a result of trauma
sustained in a fall 5.2 years after implantation. One
MRP-TITAN implant was evaluated as showing asepticloosening with axial migration > 5 mm after 0.5 years on
the conventional radiograph. It was replaced with an
MRP-TITAN implant with a larger diameter. In the
control group, five implants showing aseptic loosening
required revision surgery. In 4 of these cases, axial
migration of > 5 mm occurred within the first year; one
case showed a progressive periprosthetic radiolucency
5.6 years after implantation. In each of these cases the
stem was replaced with an MRP-TITAN implant with a
larger diameter. Additionally, 5 periprosthetic fractures
occurred in trauma sustained in a fall during the follow-
Table 2 Complication rates
Study
group
Control
group
p value
(n = 70) (n = 173)
Intraoperative Complications
shaft fissure [n] (%) 3 (4.3) 9 (5.2) 0.77
shaft fracture [n] (%) 1 (1.4) 2 (1.2) 0.86
Shaft perforation [n] (%) 2 (2.9) 4 (2.3) 0.80
Avulsion of greater trochanter [n] (%) 1 (1.4) 3 (1.7) 0.87
Sum [n] (%) 7 (10) 18 (10.4) 0.93
Postoperative Complications
Dislocations [n] (%) 5 (7.1) 10 (5.8)
Closed reduction [n] (%) 2 (2.9) 5 (2.9)
Open reduction [n] (%) 3 (4.3) 5 (2.9)
Periprosthetic fracture [n] (%) 1 (1.4) 5 (2.9)
Aseptic loosening [n] (%) 1 (1.4) 5 (2.9)
Periprosthetic infections [n] (%) 1 (1.4) 3 (1.7)
Early infection [n] (%) 0 (0) 0 (0)
Late infection [n] (%) 1 (1.4) 3 (1.7)
Postoperative complications [n] (%) 8 (11.4) 23 (13.3)
Revision surgery required [n] (%) 6 (8.6) 19 (11)
Failure rate [n] (%) 3 (4.3) 8 (4.6)
Summary of intraoperative and postoperative complications.
Table 3 Clinical outcome data
Study
group
(n = 70)
Control
group
(n = 173)
p value
Time after surgery [years] 4.4 ± 1.7 4.4 ± 1.8 0.93
Duration of operation [min.] 232 ± 63.3 186 ± 59.4 < 0.001
Hospitalization time [d] 24.4 ± 7.3 24.5 ± 6.5 0.94
Mobilization [d] 2.4 ± 1.7 2.1 ± 1 0.16
Full weight bearing [d] 9.8 ± 5,1 10.5 ± 6.8 0.39
HHS postop. 71 ± 9.1 70.2 ± 12.2 0.62
Difference in HHS (preop. vs. postop.) 35.6 ± 14.3 30.8 ± 15.8 <0.05
Table 4 Radiographic outcome
Study
group
Control
group
p value
n = 70 n = 173
Stable bony union [n] (%) 66 (94.3) 156 (90.2) 0.30
Periprosthetic radiolucencies
No periprosthetic radiolucency [n] (%) 66 (94.3) 156 (90.2) 0.30
Partial radiolucency < 1 mm [n] (%) 2 (2.9) 7 (4) 0.66
Partial radiolucency > 1 mm [n] (%) 2 (2.9) 9 (5.2) 0.43
Progressive radiolucency [n] (%) 0 (0) 1 (0.6) 0.52
Sum of radiolucencies [n] (%) 4 (5.7) 17 (9.8) 0.30
Stem migration
No stem migration [n] (%) 67 (95.7) 157 (90.8) 0.19
Stem migration < 2 mm [n] (%) 1 (1.4) 8 (4.6) 0.23
Stem migration 2–5 mm [n] (%) 1 (1.4) 4 (2.3) 0.66
Stem migration > 5 mm [n] (%) 1 (1.4) 4 (2.3) 0.66
Sum of stem migration [n] (%) 3 (4.3) 16 (9.2) 0.19
Proximal stress shielding
Proximal stress shielding [n] (%) 4 (5.7) 31 (17.9) <0.05
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In all of these cases, the stability of implant fixation was
uncompromised and the fracture was successfully trea-
ted by open reduction and internal fixation.
Periprosthetic late infections occurred in 3 cases. Two
of these cases involved reinfection after reimplantation
into a Girdlestone hip, occurring 2.7 and 3.1 years after
implantation. The other case was a new infection occur-
ring after 3.5 years. A total of 15 postoperative disloca-
tions occurred in the study and control groups [n = 5 in
the study group (7.1%); n = 10 in the control group
(5.8%), p = 0.69] within a period of 5 weeks to 3 years
postoperatively. In 7 cases [n = 2 (2.9%) in the study
group; n = 5 (2.9%) control group, p = 0.99] a closed re-
duction was sufficient, eight patients required open re-
duction [n = 3 (4.3%) in the study group vs. n = 5 (2.9%)
in the control group, p = 0.58]. Within the process of
open reduction, six times the length and/or anteversion
of the neck component was also altered, without re-
placing the femoral stem. All complications are summar-
ized in Table 3.
Radiographic evaluation
Table 4 summarizes the results of radiologic evaluation.
Radiographic evaluation showed full osteointegration of
the stem with good contact between implant and bone in
66 patients (94.3%) in the study group and in 156 patients
(90.2%) in the control group (p = 0.30). Periprostheticradiolucencies were demonstrated in 4 cases (5.7%) in the
study group and in 17 cases (9.8%) in the control group
(p = 0.30). Partial radiolucencies in the proximal zones 1
and 7 according to Gruen occurred significantly more
often in the control group without allograft augmentation
[n = 15 (8.6%) in the control group vs. n = 1 (1.4%) in the
study group vs. p = 0.04].
Axial implant migration of < 2 mm was seen in one
case in the study group as opposed to 8 cases in the con-
trol group (p = 0.23), migration of 2–5 mm also in one
case in the study group vs. 4 cases (2.3%) in the control
group (p = 0.66) and migration of > 5 mm was observed
in one case (1.4%) in the study group as opposed to 4
cases (2.3%) in the control group (p = 0.66).
Evaluation of periprosthetic bone remodeling demon-
strated a significant reduction in proximal stress shield-
ing in the study group compared with the control group
[4 cases (5.7%) vs. 31 cases (17.9%; p < 0.05)]. Secondary
stem rotation or varus or valgus tilting of more than 2°
was not observed in any of the cases.
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radiologic evaluation showed complete bony union of the
graft (Figure 3) in 66 cases (94.3%). Partial resorption
(< 25%) or, respectively, incomplete bony union was
demonstrated in only 3 cases (4.3%), whereas resorption >
25% was demonstrated in only one case (1.4%) (Table 5).
Clinical and radiographic subgroup evaluation
In a subgroup analysis (Table 6) of patients with large
metaphyseal bone defects (types IIC and III as described
by Paprosky), the study group showed significantly greater
improvement in preoperative vs. postoperative HHS (types
I, IIA and IIB: 32.75 ± 13.9 vs. 32.6 ± 15.7, p = 0.89; types
IIC and III: 44.6 ± 10.6 vs. 27.3 ± 16.1, p < 0.05).
With respect to stem diameter, patients receiving stems
with a diameter of 17 mm or larger showed significantly
greater improvement in preoperative vs. postoperative
HHS when impaction grafting was used (31.5 ± 15.6 vs.
28.6 ± 16.9 to 16 mm, p = 0.36; 41.9 ± 11.7 vs. 30.7 ± 15.1
for 17 mm or larger, p <0.05). These larger stems also
showed significantly better radiographic osteointegration
when impaction grafting was applied (92.6% vs. 81.5%;
p < 0.05), and proximal stress shielding could be reduced
significantly in the study group (p ≤ 0.05) (Table 6).
Discussion
The best strategy to achieve implant stability in revision
THA in the presence of extensive metaphyseal defects
and with a smooth-walled femoral canal is a distal dia-
physeal stem fixation concept [27]. This is especially true
for large femoral defects (types IIC and III as describedFigure 3 Radiographic assessment. Preoperative and two years postope
TITAN stem with distal diaphyseal fixation. 3.A: preoperatively, 3.B: postope
grafting. 3.B. shows consolidation of the metaphyseal allograft after impact
impaction bone grafting and stress shielding in the proximal femur.by Paprosky). The deficient proximal bone stock contra-
indicates a stem fixation concept with metaphyseal stress
transfer. Loosening rates of up to 23% have been
reported for nonmodular implants with proximal meta-
physeal stress transfer after a mean follow-up period of
1.5–13 years [18,19]. The data for this study was col-
lected over an average follow-up period of 4.4 ± 1.8 years
(2.1–9.6 years). Based on these results, the cementless
MRP-TITAN revision stem with its distal diaphyseal fix-
ation concept has proven effective in femoral revision
THA [17,25].
However, diaphyseal fixation can result in proximal
stress shielding. This may lead to bone resorption in the
non-weight-bearing proximal femur [20]. The present
results suggest that reduced stress on the proximal
femur with subsequent osteopenia resulting from dia-
physeal fixation may be expected primarily in the ab-
sence of proximal metaphyseal defect augmentation.
Evaluation of periprosthetic bone remodeling showed
stress shielding in the form of radiologically verifiable
bone resorption in 17.9% of all cases without proximal
defect augmentation. Yet this phenomenon was signifi-
cantly reduced by two thirds when the femoral impac-
tion grafting technique was used.
Andress et al. [28] examined postoperative bone re-
modeling after implantation of a cementless modular
total hip system with initial diaphyseal fixation and with-
out metaphyseal defect augmentation. Quantitative com-
puter tomography (QCT) measured a greater decrease
in periprosthetic bone density in the proximal femur
after 6 and 12 months than in the distal fixation zone.rative follow-up radiographs of revisions with implantation of a MRP-
ratively with metaphyseal defect augmentation by impaction bone
ion grafting. 3.C: preoperatively, 3.D: postoperatively without
Table 5 Radiographic graft integration
Study group
Number of hips [n] 70
Graft fixation intact [n] (%) 66 (94.3)
Bony union achieved [n] (%) 66 (94.3)
Osteolytic zone < 2 mm [n] (%) 3 (4.3)
Osteolytic zone > 2 mm [n] (%) 1 (1.4)
Graft resorption≤ 25 % [n] (%) 3 (4.3)
Graft resorption 25-75 % [n] (%) 1 (1.4)
Graft resorption > 75 % [n] (%) 0 (0)
Evaluation of periprosthetic bone remodeling and regeneration in the study group.
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preoperative bone density. The study did not demon-
strate any correlation between absolute bone density and
the relative level of the stress shielding.
In comparison, the follow-up radiographs of the
present study suggest that intraoperative allograft aug-
mentation of metaphyseal defects leads to bone regener-
ation with bone remodeling and stable biologic fixation
of the implant. Bony consolidation of the metaphyseal
femoral defects with complete bony union of the graft
was observed in 94.3% of the cases with supplementary
defect augmentation (66 cases). Pronounced bone re-
modeling in the proximal defect zone in revision arthro-
plasty with the nonmodular Wagner straight-stem
implant has been described in the literature [29-31]. Our
examination series failed to find any such remodeling
where supplementary metaphyseal grafts were not used.
Our statistical evaluation of the preoperative vs. post-
operative clinical function and the postoperative radiologic
follow-up suggests that metaphyseal graft augmentation is
advisable for large metaphyseal bone defects (Paprosky
IIC and III) and stem diameters of 17 mm and larger.
The augmentation seems to be able to regenerate theTable 6 Subgroup analysis
Femoral defects by Paprosky p-values
I IIA
Bony union 1 0.11
Sum of radiolucencies 1 0.11
Sum of stem migration 0.07 0.10
“Stress-Shielding” 0.38 0.70
HHS difference [pre- vs. post-OP] 0.34 0.93
Stem - Diameter 13 / 14 mm 15 / 16
Bony union 0.16 0.12
Sum of radiolucencies 0.16 0.12
Sum of stem migration 0.16 0.47
“Stress-Shielding” 0.39 0.30
HHS differece [pre- vs. post-OP] 0.34 0.93
Detailed evaluation of clinical and radiographic results with consideration given to
difference (p-values) between control and study group.metaphyseal defects, allowing subsequent stress transfer in
this region and facilitating integration of larger implants.
Clinical function, as expressed in the HHS, is therefore
significantly better in the study group when implants with
a diameter ≥ 17 mm. Clinical function also showed signifi-
cantly greater improvement after Impaction Bone Grafting.
But with respect to the ranges and the overall outcome
and survival, which did not vary significantly, the clinical
relevance to our patients of these statistical finding remains
questionable.
The rate of aseptic loosening was 1.4% (1 case) in the
study group and 2.9% (5 cases) in the control group with
corresponding Kaplan-Meier survival rates of 95.7% vs.
93.1% after 8.54 and 8.7 years, respectively (Figure 4).
Though this does not allow a definitive assessment of
the long-term suitability of the MRP-TITAN revision
implant, the results appear very encouraging in compari-
son with reported rates of aseptic loosening of 7-26% for
femoral revision THA [32].
Axial implant migration ≥5 mm within one year of sur-
gery without secondary stabilization was observed in a
total of 5 cases. Results of the Norwegian Arthroplasty
Register show 3 cases of aseptic loosening in a series of 89
femoral revisions within one year of surgery [33]). The
cause was presumably an insufficient initial diaphyseal
press fit without secondary stabilization. To minimize the
risk of axial migration, it is important to use stems in a
sufficient diameter in relation to the femoral canal. Short-
stemmed implants with larger distal diameters should be
preferred to longer, more slender stems. Additionally, care
must be taken to achieve proper rotation when using a
curved MRP-TITAN stem. A three point fixation instead
of the desired diaphyseal press fit fixation has to be
avoided. Here the risk of significant subsidence with ex-
cessive stress on the bone adjacent to the tip of the stem,
leading to a periprosthetic stress fracture [30], can arise.IIB IIC III
0.17 0.07 <0.05
0.17 0.07 <0.05
0.13 <0.05 0.07
0.94 <0.05 <0.05
0.32 <0.05 <0.05
mm 17 / 18 mm 19 / 20 mm > 21 mm
0.08 0.08 0.08
0.08 0.08 0.08
0.11 0.08 0.08
<0.05 <0.05 0.08
<0.05 <0.05 <0.05
the femoral defect situation and implant diameter: levels of significance in
Figure 4 Kaplan-Meier survival rate in the study group and in
the control group.
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graphic evidence of secondary stabilization within the
first year postoperatively without signs of further subsid-
ence during the follow-up period. A comparison with
published studies of cementless, nonmodular straight-
stem revision implants such as the Wagner implant
shows that the axial migration process occurs almost
invariably with this implant design. The majority of
Wagner implants in the relevant studies showed sec-
ondary stabilization after 3–13 months [33,34] with a
mean migration rate of 3.2-6.1 mm [33-35]. Boehm and
Bischel report on axial migration > 5 mm in 34% of all
cases and > 10 mm in 20% in patients with 129 Wagner
implants and a mean follow-up of 4.8 years (2 months
to 11.1 years) [34].
The fact that the MRP-TITAN implant showed less
axial migration compared with the cementless Wagner
stem may be caused by the specific geometry of the im-
plant design. The distal support and the press fit in the
anterior bow of the femur provide rotational stability in
addition to axial support. The crucial factor surgically is
to ream the diaphyseal femoral canal to achieve a broad
area of contact between implant and cortical bone over
a distance of at least 7 cm. This will ensure stable distal
fixation. The stellate arrangement of relatively sharp ribs
on the MRP-TITAN stem and the tapered design pro-
vide sufficient preloading in the often sclerotic diaphy-
seal bone. This ensures initial axial and rotational
stability. This construct, combined with the rough
corundum-blasted implant surface facilitates bone in-
growth for secondary biologic fixation.The number of intraoperative complications did not
differ significantly between the study and control group.
In particular, there were no significant differences in the
numbers of intraoperative shaft fissures/fractures. Com-
pared with rates of up to 21% reported in the literature
[36], the rate of shaft fissures/fractures (n = 8 (11.4%) in
the study group and n = 24 (13.9%) in the control group)
is low. Cerclage wires can help to avoid iatrogenic frac-
tures and fissures while reaming the canal, placing the
tapered implant, and impacting the metaphyseal allo-
graft. Especially in fragile and thin cortical bone, the
prophylactic placement of cerclage wires in the diaphy-
seal fixation zone as well as in the metaphyseal augmen-
tation zone should be considered. Within the follow-up
the total rate of periprosthetic fractures [n = 1 (1.4%) in
the study group vs. n = 5 (2.9%) in the control group]
was comparable to those reported in other studies
[11,32,37]. In each of these cases the periprosthetic frac-
tures resulted from sufficient trauma. No case was
observed in which excessive stresses acting on the bone
adjacent to the tip of the implant stem eventually led to
periprosthetic stress fractures from three point fixation
of the implant.
Limitations
Our study has potential shortcomings. The decision to
use impaction grafting was made intraoperatively based
on clinical criteria such as defect size, defect location
and containment, rather than using a randomized pa-
tient allocation. However, the both groups did not vary
significantly according to age, sex, weight, body mass
index (BMI), and surgical parameters. Another limitation
is that multiple surgeons performed the operations. Even
though all of them were experienced attending-surgeons
and all of them used the MRP-TITAN stem and the
same Impaction Grafting System this might have com-
promised our results. With a mean follow-up period of
4.4 ± 1.8 years, the present study does not allow a defini-
tive assessment of the long-term results of impaction
bone grafting technique. Due to the limitations of a
retrospective and descriptive study the level of evidence
remains low. A future prospective controlled trial seems
essential.
Conclusion
We present, to the best of our knowledge, the largest co-
hort on impaction grafting in combination with cement-
less distal diaphyseal stem fixation published so far. Our
hypothesis was that impaction bone grafting improves
the survival when using the MRP-TITAN stem. Our ana-
lysis provides initial evidence of sufficient bone regener-
ation with graft augmentation of metaphyseal bone
defects. There was a statistical significant reduction
in proximal stress shielding and in periprosthetic
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corresponded to a significant improvement in clinical
function, expressed as the increase in the postoperative
HHS.
Our data suggests, that proximal metaphyseal graft
augmentation should be considered in revision THA
with large metaphyseal bone defects (types IIC and III as
described by Paprosky) and with stem diameters of
17 mm and above.
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